Matthew Dodds Boston Quotations

Even with the new components of the Boston offer, we don't think Guidant's board will get comfortable enough with the aforementioned antitrust issues and the extra $1.

Boston's overall sales growth is going to slip to 5 percent in the second half of this year and go flat in 2006. The new-product portfolio Boston is piecing together can restore double-digit earnings and sales growth, but it will probably take until 2009.

Boston Scientific has a couple of more weeks if needed to complete due diligence.

It seems like (Johnson & Johnson and Boston Scientific) are going to dominate the market at least through '06.